Posts Tagged ‘Peter Hotez’

NTDs in Central Asia has me losing sleep

October 27th, 2011

A terrifying parasite.

By: Alanna Shaikh

Dr. Peter Hotez is trying to ruin my life. That’s the only reason I can find for his new article on “Central Asia’s hidden burden of neglected tropical diseases,” which was published last month in PLOS Neglected Tropical Diseases.  I was already borderline obsessive about NTDs and the risk of getting them in my family. My only comfort was that we live in Tajikistan, which is far, far away from most major NTD–endemic areas. Dr. Hotez and his co-author, Dr. Ken Alibek of Nazarbayev University in Astana, Kazakhstan, have now taken even that small comfort from me. I may never sleep uninterrupted again. Last night I had a nightmare about glow in the dark helminthes.[1]

So, what is Central Asia’s hidden burden of NTDs? Well, they do not glow in the dark to my knowledge, but worms, worms, worms, in a big way. First, the soil-transmitted helminthes: “A study of rural primary schools in southwestern Kyrgyzstan found that many of the children had at least one soil-transmitted helminth infection.” Okay, I can ignore that somewhat. I wear shoes, I live in a nice house, I don’t farm for a living. But there’s more: “In four of the Central Asian nations, cystic echinococcosis — a tapeworm infection spread by dogs and sheep — has increased at least four-fold and is thought to be vastly under-reported.” But my dogs get worm prophylaxis, I avoid stray dogs, and I only see sheep up close as well-cooked mutton. Tapeworms can’t leap through my car window or survive being baked and boiled into plov. » Read more: NTDs in Central Asia has me losing sleep

Chagas disease vaccine research led by Peter Hotez at Baylor

October 11th, 2011

Sabin Vaccine Institute President Dr. Peter Hotez is leading the research at Texas Children’s Hospital and Baylor College of Medicine to develop the first-ever vaccine for Chagas disease. Approximately 18 million people worldwide are affected by the disease, mostly in parts of Latin America and the Caribbean, and can also be found in parts of North America. Caused by the parasite called Trypanosoma cruzi (T. cruzi), Chagas is transmitted by a bite from the vanchuga bug, and can lead to heart disease and digestive complications.

Having recently moved to Houston, Texas to take his position as dean of the National School of Tropical Medicine at Baylor, Dr. Hotez announced last week that he is in the preliminary stages of research for a Chagas vaccine, where then the development of the vaccine will take place at the Sabin Vaccine Institute & Texas Children’s Hospital Center for Vaccine Development. Take a look at the excerpt below or read the full story on the Austin-American Statesman.

“Responding to an article we published today about little-known Chagas disease, the Sabin Vaccine Institute & Texas Children’s Hospital Center for Vaccine Development in Houston informed us that one of its nationally known doctors is working on a vaccine.

Dr. Peter Hotez, dean of the National School of Tropical Medicine at Baylor and president of the Sabin institute (a partnership with Texas Children’s Hospital), said his research is in the early stages. It could take a decade for his vaccine to be available, if all goes well. Researchers in other countries also are working on a Chagas vaccine.

Chagas is a serious disease that is common in Latin American but is believed to be a greater threat in Texas than previously thought to dogs and people, based on research done by University of Texas Professor Sahotra Sarkar.”

Dr. Peter Hotez Awarded for Excellence in Inter-American Public Health

September 28th, 2011

Photo credit: PAHO/PAHEF

We are proud to announce that Dr. Peter Hotez, president of the Sabin Vaccine Institute, is the 2011 recipient of the Abraham Horwitz Award for Excellence in Inter-American Public Health.  Awarded by the Pan American Health and Education Foundation (PAHEF) and the Pan American Health Organization (PAHO), the Horwitz Award recognizes Dr. Hotez for his dedication to improving the lives of the impoverished and his tireless work in public health within the Americas.

Dr. Peter Hotez receives the prestige Horwitz Award

This award’s recognition of Dr. Hotez showcases the great progress being made in neglected tropical disease research, advocacy and prevention, but there is still much work to be done in our efforts to end the neglect. Check out the full press release below:

Pioneering scientist Dr. Peter Hotez wins major award for Excellence in Inter-American Public Health

The Abraham Horwitz award will honor Dr. Hotez’s extensive work in global health over the past 30 years

WASHINGTON, D.C.-Sept. 26, 2011- Dr. Peter Hotez, president of the Sabin Vaccine Institute, was honored today with the prestigious Abraham Horwitz Award for Excellence in Inter-American Public Health.  The annual award, presented jointly by the Pan American Health and Education Foundation (PAHEF) and the Pan American Health Organization (PAHO), recognized the major public health contributions that Hotez has made to improve the lives of people living in the Americas. » Read more: Dr. Peter Hotez Awarded for Excellence in Inter-American Public Health

Dr. Peter Hotez Calls for More Attention to NTDs in Central Asia

September 28th, 2011

Here at End the Neglect, we’re pleased to share a new research study co-authored by Dr. Peter Hotez, president of the Sabin Vaccine Institute, published today by the Public Library of Science (PLoS). The article highlights the underappreciated burden of neglected tropical diseases in Central Asia and addresses the need for increased surveillance and control programs in order to end the neglect.

A link to the PLoS article can be found here, and the full press release is below:

Central Asia’s Hidden Burden of Neglected Tropical Diseases

High rates of parasitic infection in the region nearly 20 years after the collapse of the Soviet Union

The open-access journal PLoS Neglected Tropical Diseases will publish an article emphasizing the rising burden of Neglected Tropical Diseases (NTDs) in Central Asia on Tuesday, Sept. 27th. According to the article’s co-authors, Dr. Peter Hotez, President of the Sabin Vaccine Institute, and Dr. Ken Alibek of Nazarbayev University in Astana, Kazakhstan, the region continues to suffer from a post-Soviet economic breakdown that may have contributed to a re-emergence of several NTDs in the area, especially among its most economically disadvantaged groups.

» Read more: Dr. Peter Hotez Calls for More Attention to NTDs in Central Asia